NCT00347100 - Insulin Glargine in Type 2 Diabetic Patients | Biotech Hunter

Enrollment

387

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

May 31, 2008

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

Insulin Glargine

Throughout study period

DRUG

Glyburide

Combination throughout the study period. Titrate to FPG ≤ 100 mg/dl.

DRUG

Glyclazide

Combination throughout the study period. Titrate to FPG ≤ 100 mg/dl.

DRUG

Glimiperide

Combination throughout the study period. Titrate to FPG ≤ 100 mg/dl.

DRUG

Glipizide

Combination throughout the study period. Titrate to FPG ≤ 100 mg/dl.

DRUG

Metformin

Combination throughout the study period. Titrate to FPG ≤ 100 mg/dl.

Trial Locations (1)

Sanofi-Aventis, Beijing